Richard Ferrari - 26 Apr 2022 Form 3 Insider Report for Tenon Medical, Inc. (TNON)

Role: Director
Signature: /s/ Richard Ferrari
Issuer symbol: TNON
Transactions as of: 26 Apr 2022
Net transactions value: $0
Form type: 3
Filing time: 26 Apr 2022, 21:31:28 UTC
Previous filing: 15 Nov 2021
Next filing: 16 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TNON	Common Stock						158,132	26 Apr 2022	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TNON	Stock Options							26 Apr 2022	Common Stock	160,751	$7.06	Direct	F2, F3
holding	TNON	Stock Options							26 Apr 2022	Common Stock	112,500	$5.20	Direct	F4, F5
holding	TNON	Stock Options							26 Apr 2022	Common Stock	13,670	$0.6200	See footnote	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of (i) 65,918 shares held by TCTIG, LLC for which Richard Ferrari has a 25% equity interest therein and has control over how TCTIG, LLC will vote 25% of the shares of common stock held by TCTIG, LLC and (ii) 92,214 shares of common stock issuable to Ferrari Family Trust, for which Richard Ferrari is the trustee, upon the automatic conversion of a convertible note on the closing of the initial public offering of Tenon Medical, Inc. to occur on April 29, 2022.
F2	Richard Ferrari was granted an option to purchase 321,502 shares (or 160,751 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $3.53 (or $7.06 post-split) per share with a grant date of July 19, 2021, subject to monthly equal vesting over a three-year period commencing July 19, 2021.
F3	40,187 shares of common stock underlying stock options granted on July 19, 2021 have vested and are exercisable as of April 26, 2022.
F4	Richard Ferrari was granted an option to purchase 225,000 shares (or 112,500 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $2.60 (or $5.20 post-split) per share with a grant date of May 1, 2021, subject to monthly equal vesting over a three-year period commencing January 1, 2021.
F5	46,875 shares of common stock underlying stock options granted on May 1, 2021 have vested and are exercisable as of April 26, 2022.
F6	Option shares held by TCTIG, LLC for which Richard Ferrari has a 25% equity interest therein and has control over how TCTIG, LLC will vote 25% of the shares of common stock held by TCTIG, LLC. TCTIG, LLC was granted an option to purchase 109,353 shares (or 54,677 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $0.31 (or $0.62 post-split) per share with a grant date of June 19, 2014, which fully vested upon issuance.